Aaron G.L. Fletcher
CIK 1789490 · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.69M
Companies
7
Total Filings
40
Lifetime Open-Market Net
$40.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACTU | Director | 60,973 | $1.06 | $64.6K | $5.00M | 3 | 2026-05-22 |
| CGTX | Director | 475,155 | $0.92 | $438.8K | $2.28M | 2 | 2025-09-23 |
| AZTR | 10%+ Owner | 680 | $0.13 | $88 | $24.00M | 1 | 2023-06-23 |
| CUE | Director | 36,833 | $30.25 | $1.11M | $4.48M | 9 | 2023-01-05 |
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | Director | 10,123 | $0.07 | $658 | $4.40M | 11 | 2022-12-30 |
| SWK Holdings Corp (SWKH) Delisted | Director | 9,873 | $15.90 | $157.0K | $0 | 9 | 2022-01-12 |
| INAB | 10%+ Owner | 62,554 | $1.11 | $69.4K | $0 | 2 | 2021-08-17 |
Recent Filings · Page 3 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-01 | SWK Holdings Corp (SWKH) Delisted | Grant (A) | +250 | $0 | EDGAR |
| 2021-01-06 | CUE | Grant (A) | — | $0 | EDGAR |
| 2021-01-04 | SWK Holdings Corp (SWKH) Delisted | Grant (A) | +250 | $0 | EDGAR |
| 2020-11-25 | CUE | Buy (P) | +6,548 | $82.8K | EDGAR |
| 2020-11-24 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +5,000 | $75.7K | EDGAR |
| 2020-10-01 | SWK Holdings Corp (SWKH) Delisted | Grant (A) | +1,911 | $0 | EDGAR |
| 2020-08-26 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-02 | SWK Holdings Corp (SWKH) Delisted | Grant (A) | +1,419 | $0 | EDGAR |
| 2020-06-25 | CUE | Buy (P) | +7,500 | $186.6K | EDGAR |
| 2020-05-26 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +20,000 | $101.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.